Otmar Wiestler
Supervisory board member joins Bayer
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler
Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
